Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Efficacy and safety of daclatasvir-based antiviral therapy in HCV recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multi-centre cohort study.

Salcedo M, Prieto M, Castells L, Pascasio JM, Alvarez JLM, Fernández I, Sánchez-Antolín G, González-Diéguez L, García-Gonzalez M, Otero A, Lorente S, Espinosa MD, Testillano M, González A, Castellote J, Casafont F, Londoño MC, Pons JA, Molina Pérez E, Cuervas-Mons V, Pascual S, Herrero JI, Narváez I, Vinaixa C, Llaneras J, Sousa JM, Bañares R.

Transpl Int. 2017 Jun 13. doi: 10.1111/tri.12999. [Epub ahead of print]

PMID:
28608619
2.

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.

Aguiar D, Martínez-Urbistondo D, Baroja-Mazo A, de la Mata M, Rodríguez-Perálvarez M, Rubín A, Puchades L, Serrano T, Montero J, Cuadrado A, Casafont F, Salcedo M, Rincón D, Pons JA, Herrero JI.

Ann Transplant. 2017 May 2;22:265-275.

3.

Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy.

Puente Á, Cabezas J, López Arias MJ, Fortea JI, Arias MT, Estébanez Á, Casafont F, Fábrega E, Crespo J.

Rev Esp Enferm Dig. 2017 Jan;109(1):17-25. doi: 10.17235/reed.2016.4235/2016.

4.

De Novo Donor-Specific Anti-Human Leukocyte Antigen Antibody Detection in Long-Term Adult Liver Transplantation.

San Segundo D, Alonso C, Ruiz P, Roman I, Arias-Loste MT, Cuadrado A, Puente A, Casafont F, López-Hoyos M, Crespo J, Fábrega E.

Transplant Proc. 2016 Nov;48(9):2980-2982. doi: 10.1016/j.transproceed.2016.08.037.

PMID:
27932124
5.

Serum Levels of Interleukin-34 During Acute Rejection in Liver Transplantation.

San Segundo D, Ruiz P, Irure J, Arias-Loste MT, Cuadrado A, Puente A, Casafont F, López-Hoyos M, Crespo J, Fábrega E.

Transplant Proc. 2016 Nov;48(9):2977-2979. doi: 10.1016/j.transproceed.2016.08.038.

PMID:
27932123
6.

Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.

Fortún J, Muriel A, Martín-Dávila P, Montejo M, Len O, Torre-Cisneros J, Carratalá J, Muñoz P, Fariñas C, Moreno A, Fresco G, Goikoetxea J, Gavaldá J, Pozo JC, Bodro M, Vena A, Casafont F, Cervera C, Silva JT, Aguado JM; Grupo de Estudio de Infección en Pacientes Trasplantados-Grupo de Estudio de Micología Médica (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica), and Red Española de Investigación en Patología Infecciosa.

Liver Transpl. 2016 Apr;22(4):427-35. doi: 10.1002/lt.24391.

7.

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.

Agüero F, Forner A, Manzardo C, Valdivieso A, Blanes M, Barcena R, Rafecas A, Castells L, Abradelo M, Torre-Cisneros J, Gonzalez-Dieguez L, Salcedo M, Serrano T, Jimenez-Perez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators.

Hepatology. 2016 Feb;63(2):488-98. doi: 10.1002/hep.28321. Epub 2016 Jan 4.

PMID:
26516761
8.

Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study.

Agüero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C, Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F, Nishida S, Gastaca M, Miró JM; FIPSE/NIH HIVTR/NEAT023 Investigators.

Am J Transplant. 2016 Feb;16(2):679-87. doi: 10.1111/ajt.13461. Epub 2015 Sep 28.

9.

[V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list].

Pardo F, Pons JA, Briceño J; en nombre de la Sociedad Española de Trasplante Hepático.

Gastroenterol Hepatol. 2015 Dec;38(10):600-18. doi: 10.1016/j.gastrohep.2015.06.008. Epub 2015 Sep 26. Spanish.

PMID:
26404045
10.

Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe.

Pérez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavaldá J, Aydillo TA, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, Blanes M, Fortún J, Suárez-Benjumea A, López-Medrano F, Barranco JL, Peghin M, Roca C, Lara R, Cordero E; Influenza Vaccine in Solid Organ Transplant Recipient Study Group, Spanish Network of Research in Infectious Diseases (REIPI-GESITRA); Influenza Vaccine in Solid Organ Transplant Recipient Study Group Spanish Network of Research in Infectious Diseases REIPI-GESITRA.

Clin Microbiol Infect. 2015 Nov;21(11):1040.e11-8. doi: 10.1016/j.cmi.2015.07.014. Epub 2015 Jul 29.

11.

Galectin-1 in stable liver transplant recipients.

García MJ, Jurado F, San Segundo D, López-Hoyos M, Iruzubieta P, Llerena S, Casafont F, Arias M, Puente Á, Crespo J, Fábrega E.

Transplant Proc. 2015 Jan-Feb;47(1):93-6. doi: 10.1016/j.transproceed.2014.12.001.

PMID:
25645780
12.

Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin.

Buti M, Tabernero D, Mas A, Homs M, Prieto M, Rodríguez-Frías F, Casafont F, Casillas R, González A, Miras M, Herrero JI, Castells L, Esteban R.

Transpl Infect Dis. 2015 Apr;17(2):208-20. doi: 10.1111/tid.12360.

PMID:
25641570
13.

Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.

Castells L, Rimola A, Manzardo C, Valdivieso A, Montero JL, Barcena R, Abradelo M, Xiol X, Aguilera V, Salcedo M, Rodriguez M, Bernal C, Suarez F, Antela A, Olivares S, Del Campo S, Laguno M, Fernandez JR, de la Rosa G, Agüero F, Perez I, González-García J, Esteban-Mur JI, Miro JM; FIPSE LT-HIV Investigators.

J Hepatol. 2015 Jan;62(1):92-100. doi: 10.1016/j.jhep.2014.07.034. Epub 2014 Aug 13. Erratum in: J Hepatol. 2016 Mar;64(3):757.

PMID:
25127748
14.

The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

Roman A, Manito N, Campistol JM, Cuervas-Mons V, Almenar L, Arias M, Casafont F, del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Serón D, Ussetti P; ATOS working group.

Transplant Rev (Orlando). 2014 Apr;28(2):84-91. doi: 10.1016/j.trre.2014.01.001. Epub 2014 Jan 27. Review.

PMID:
24602805
15.

Etiologies and outcomes of acute liver failure in a spanish community.

Fábrega E, Mieses MÁ, Terán A, Moraleja I, Casafont F, Crespo J, Pons-Romero F.

Int J Hepatol. 2013;2013:928960. doi: 10.1155/2013/928960. Epub 2013 Aug 19.

16.

New concepts and best practices for management of pre- and post-transplantation cancer.

Campistol JM, Cuervas-Mons V, Manito N, Almenar L, Arias M, Casafont F, Del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Román A, Serón D, Ussetti P; ATOS Working Group.

Transplant Rev (Orlando). 2012 Oct;26(4):261-79. doi: 10.1016/j.trre.2012.07.001. Epub 2012 Aug 15. Review.

PMID:
22902168
17.

Interleukin-9 in stable liver transplant recipients.

Fábrega E, López-Hoyos M, San Segundo D, Casafont F, Moraleja I, Sampedro B, Pons-Romero F.

Transplant Proc. 2012 Jul-Aug;44(6):1536-8. doi: 10.1016/j.transproceed.2012.05.014.

PMID:
22841206
18.

Serum levels of interleukin-9 during acute rejection in liver transplantation.

Fábrega E, López-Hoyos M, San Segundo D, Casafont F, Angel Mieses M, Sampedro B, Pons-Romero F.

Transplant Proc. 2012 Jul-Aug;44(6):1533-5. doi: 10.1016/j.transproceed.2012.05.013.

PMID:
22841205
19.

Liver retransplantation in HIV-infected patients: a prospective cohort study.

Gastaca M, Aguero F, Rimola A, Montejo M, Miralles P, Lozano R, Castells L, Abradelo M, Mata Mde L, San Juan Rodríguez F, Cordero E, Campo Sd, Manzardo C, de Urbina JO, Pérez I, Rosa Gde L, Miro JM; FIPSE OLT-HIV investigators.

Am J Transplant. 2012 Sep;12(9):2465-76. doi: 10.1111/j.1600-6143.2012.04142.x. Epub 2012 Jun 15.

20.

Chemoprophylaxis with isoniazid in liver transplant recipients.

Fábrega E, Sampedro B, Cabezas J, Casafont F, Mieses MÁ, Moraleja I, Crespo J, Pons-Romero F.

Liver Transpl. 2012 Sep;18(9):1110-7. doi: 10.1002/lt.23480.

Supplemental Content

Loading ...
Support Center